Ignite Creation Date:
2024-05-06 @ 1:36 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04067336
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2019-06-25
Brief Title:
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Kura Oncology Inc
Organization:
Kura Oncology Inc
Organization Data
Organization:
Kura Oncology Inc
Class:
INDUSTRY
Study ID:
KO-MEN-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kura Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None